AYTU BIOPHARMA, INC financial data

Symbol
AYTU on Nasdaq
Location
Denver, CO
Fiscal year end
30 June
Latest financial report
10-Q - Q4 2025 - 03 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 116% %
Quick Ratio 16% % -12%
Return On Assets -20% % -351%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 10,733,208 shares 74%
Common Stock, Shares, Outstanding 10,733,208 shares 74%
Entity Public Float $7,238,109 USD -32%
Common Stock, Value, Issued $1,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 10,036,359 shares 64%
Weighted Average Number of Shares Outstanding, Diluted 10,036,359 shares 18%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $62,640,000 USD 2%
Research and Development Expense $378,000 USD -85%
Selling and Marketing Expense $21,295,000 USD -1.9%
General and Administrative Expense $17,799,000 USD -3.4%
Operating Income (Loss) $8,676,000 USD -34%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $24,244,000 USD -900%
Income Tax Expense (Benefit) $315,000 USD -79%
Net Income (Loss) Attributable to Parent $24,443,000 USD -366%
Earnings Per Share, Basic -3.37 USD/shares -247%
Earnings Per Share, Diluted -1.05 USD/shares -304%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $30,025,000 USD 47%
Accounts Receivable, after Allowance for Credit Loss, Current $30,923,000 USD 22%
Inventory, Net $8,656,000 USD -22%
Other Assets, Current $63,053,000 USD 4630%
Assets, Current $76,241,000 USD
Property, Plant and Equipment, Net $484,000 USD -6.2%
Operating Lease, Right-of-Use Asset $959,000 USD -19%
Intangible Assets, Net (Excluding Goodwill) $43,578,000 USD -13%
Other Assets, Noncurrent $738,000 USD -52%
Assets $122,000,000 USD 5%
Accounts Payable, Current $14,259,000 USD 22%
Employee-related Liabilities, Current $2,291,000 USD -42%
Accrued Liabilities, Current $40,156,000 USD 2%
Liabilities, Current $65,563,000 USD 2.4%
Long-term Debt and Lease Obligation $9,998,000 USD 0.15%
Operating Lease, Liability, Noncurrent $973,000 USD -12%
Other Liabilities, Noncurrent $4,901,000 USD -2.9%
Retained Earnings (Accumulated Deficit) $342,154,000 USD -7.7%
Stockholders' Equity Attributable to Parent $14,201,000 USD -54%
Liabilities and Equity $122,000,000 USD 5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $618,000 USD 48%
Net Cash Provided by (Used in) Financing Activities $2,296,000 USD 152%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 10,733,208 shares 74%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $1,678,000 USD 1545%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19,800,000 USD 3.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities $466,000 USD 27%
Deferred Tax Assets, Valuation Allowance $136,552,000 USD -0.51%
Deferred Tax Assets, Gross $136,804,000 USD -0.88%
Operating Lease, Liability $1,171,000 USD -9.1%
Depreciation $200,000 USD -60%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $2,202,000 USD -16%
Property, Plant and Equipment, Gross $1,252,000 USD 7.3%
Operating Lease, Liability, Current $198,000 USD 8.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two $386,000 USD 2.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $331,000 USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.114 pure -5.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $317,000 USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three $358,000 USD -7.3%
Deferred Tax Assets, Operating Loss Carryforwards $119,782,000 USD 0.51%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $518,000 USD -61%
Lessee, Operating Lease, Liability, to be Paid, Year Four $230,000 USD -36%
Operating Lease, Payments $100,000 USD -50%
Additional Paid in Capital $356,354,000 USD 2.3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $2,811,000 USD -24%
Deferred Tax Assets, Net of Valuation Allowance $252,000 USD -67%
Share-based Payment Arrangement, Expense $649,000 USD -56%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%